Annual report pursuant to Section 13 and 15(d)

Segment Reporting (Tables)

v3.22.4
Segment Reporting (Tables)
12 Months Ended
Dec. 31, 2022
Segment Reporting [Abstract]  
Schedule of Segment Reporting Information, by Segment The tables below present financial information for the Company’s two operating business segments.
Year Ended December 31,
2022 2021
Revenues:
Corporate clinics $ 59,422,294  $ 44,348,234 
Franchise operations 42,489,115  36,511,419 
Total revenues $ 101,911,409  $ 80,859,653 
Depreciation and amortization:
Corporate clinics $ 6,554,852  $ 5,446,663 
Franchise operations 744,172  334,945 
Corporate administration 344,956  307,339 
Total depreciation and amortization $ 7,643,980  $ 6,088,947 
Segment operating income:
Corporate clinics $ (887,101) $ 4,432,872 
Franchise operations 19,586,367  16,706,643 
Unallocated corporate (16,622,405) (15,787,096)
Total segment operating income $ 2,076,861  $ 5,352,419 
Reconciliation of total segment operating income to consolidated earnings before income taxes:
Total segment operating income $ 2,076,861  $ 5,352,419 
Other (expense), net (133,101) (69,878)
Income before income tax expense (benefit) $ 1,943,760  $ 5,282,541 
Schedule of Reconciliation of Assets from Segment to Consolidated
December 31, 2022 December 31, 2021
Segment assets:
Corporate clinics $ 57,947,468  $ 40,722,898 
Franchise operations 12,360,878  12,593,912 
Total segment assets $ 70,308,346  $ 53,316,810 
Unallocated cash and cash equivalents and restricted cash $ 10,550,417  $ 19,912,338 
Unallocated property and equipment 915,216  857,176 
Other unallocated assets 10,169,193  11,367,885 
Total assets $ 91,943,172  $ 85,454,209